We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.59B
1-Year Est. Return 234.06%
This Fund
S&P 500
This Quarter Est. Return
-2.29%
1 Year Est. Return
+234.06%
3 Year Est. Return
+822.97%
5 Year Est. Return
+865.41%
10 Year Est. Return
+12,585.11%
AUM
$2.75B
AUM Growth
-$127M
Cap. Flow
+$174M
Cap. Flow %
6.34%
Top 10 Hldgs %
80.34%
Holding
44
New
6
Increased
1
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
MRSN
Mersana Therapeutics
MRSN
+$113M
2
TNTR
Tintri, Inc. Common Stock
TNTR
+$38.2M
3
SNAP icon
Snap
SNAP
+$16.4M
4
SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
+$12.8M
5
SENS icon
Senseonics Holdings Inc
SENS
+$11.3M

Top Sells

Rank Stock Value
1
GRPN icon
Groupon
GRPN
+$17.4M
2
HIVE
Aerohive Networks
HIVE
+$14.2M

Sector Composition

Rank Sector Weight
1 Healthcare 94.39%
2 Communication Services 1.93%
3 Technology 1.89%
4 Consumer Discretionary 1.79%
5 Miscellaneous 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RIGL icon
26
Rigel Pharmaceuticals
RIGL
$829M
$8.85M 0.32%
324,315
– –
TRVN
27
DELISTED
Trevena, Inc.
TRVN
$8.77M 0.32%
6,099
– –
AFMD
28
DELISTED
Affimed
AFMD
$7.97M 0.29%
388,889
– –
VRNA
29
DELISTED
Verona Pharma
VRNA
$7.77M 0.28%
+666,666
New +$8.83M
TCON
30
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$6.62M 0.24%
13,796
– –
DZSI
31
DELISTED
DZS Inc. Common Stock
DZSI
$5.74M 0.21%
956,255
– –
HIVE
32
DELISTED
Aerohive Networks
HIVE
$5.61M 0.2%
1,121,080
-3,188,611
-74% -$14.2M
SYBX
33
DELISTED
Synlogic
SYBX
$4.97M 0.18%
28,332
– –
TRIL
34
DELISTED
Trillium Therapeutics Inc.
TRIL
$4.62M 0.17%
+1,050,000
New +$5.81M
CSBR icon
35
Champions Oncology
CSBR
$66.4M
$4.02M 0.15%
1,562,500
– –
ORKA
36
Oruka Therapeutics
ORKA
$6.1B
$3.5M 0.13%
6,760
– –
VIRX
37
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3.5M 0.13%
37,094
– –
ARQL
38
DELISTED
Arqule Inc
ARQL
$3.13M 0.11%
2,520,316
– –
ROKA
39
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$2.31M 0.08%
893,471
– –
AKTX
40
Akari Therapeutics
AKTX
$20M
$2.08M 0.08%
565
– –
PRTK
41
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.6M 0.06%
66,245
– –
OREX
42
DELISTED
Orexigen Therapeutics, Inc.
OREX
$1.08M 0.04%
370,900
– –
AVTX icon
43
Avalo Therapeutics
AVTX
$862M
$341K 0.01%
207
– –
GYRE icon
44
Gyre Therapeutics
GYRE
$709M
$202K 0.01%
5,799
– –
1
2

Similar funds

ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return
CCP
Cryder Capital Partners London, United Kingdom $1.59B AUM 0.23% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
W
Wealthquest Cincinnati, Ohio $1.59B AUM 18.1% 1-Year Est. Return
PIS
PPSC Investment Service Tokyo, Japan $1.58B AUM 47.89% 1-Year Est. Return
FWP
Falcon Wealth Planning Ontario, California $1.58B AUM 20.99% 1-Year Est. Return

NEA Management Company's Q2 2017 Portfolio in Review

As of Q2 2017, NEA Management Company held 44 positions worth $2.75B, down 4.4% from $2.88B the previous quarter. Its ten largest holdings account for 80% of the portfolio.

NEA Management Company deployed $174M of net new capital in Q2 2017, opening 6 new positions and adding to 1 existing holding. Its largest new stake was Mersana Therapeutics: 325,771 shares worth $114M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 96% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Groupon, an estimated $17.4M trimmed.

  • NEA Management Company's largest Q2 2017 buy was Mersana Therapeutics: 325,771 shares worth $114M.
  • NEA Management Company added most to Senseonics Holdings Inc in Q2 2017, an estimated $11.3M increase.
  • NEA Management Company's biggest Q2 2017 reduction was Groupon, cutting an estimated $17.4M.
  • NEA Management Company's ten largest holdings make up 80% of its $2.75B portfolio in Q2 2017.
  • NEA Management Company opened 6 new positions and closed 0 in Q2 2017.
  • NEA Management Company's portfolio value fell 4.4% quarter-over-quarter to $2.75B.

Based on NEA Management Company's 13F filing for Q2 2017, filed 26 Jul 2017.